P-235 E-health monitoring during pancreatic cancer treatment

Abstract

Technologies of digital support for oncological patients through mobile applications is a trend. The so-called “e-health” is already a reality in hospitals across the world. The WeCancer App is an electronic patient-reported outcome tool, which also provides on-demand multidisciplinary digital support from nurses, psychologists, and nutritionists. It also encompasses real-time remote patient monitoring, a notification center to patient and medical staff, symptom monitoring, medication control, and a content hub with reliable medical information. This study examined whether daily symptom reporting (with electronic patient-reported outcomes [e-PROs]) in pancreatic cancer patients is feasible. Patients could report sixteen common symptoms through a mobile application, on their smartphones and tablets, for monitoring, symptom management, and follow-up with a specialized nurse, who determines care based on digital support clinical protocols through online chat. The nursing team action started at the moment of patient inclusion with the tutorial to download the App and training with the patient/caregiver. From January 2020 to March 2021, 44 eligible patients were enrolled in this study. The e-PRO completion rates were > 90% at baseline, and ≥ 50% at all on-treatment assessments and adherence. In App adherence, 99 reports were made. 53 (53,54%) symptoms, 14 (14,14%) sleep, 12 (12,12%) weight, and 7 (7,07%) gratitude. The most reported symptoms were: tiredness (18,87%), pain (16,98%), dysphagia (9,43%), nausea (7,55%). Pancreatic cancer patients' reports are feasible through e-health. The results suggest that further research should be done to prove the effectiveness of the App.